NUP37 and hepatocellular carcinoma: OS analysis showed that HCC patients with MCM2 or NUP37 high expression had worse OS (median OS, 37.3 (29.2–45.3) months vs. 59.5 (53.4–65.6) months; p = 0.00019, log-rank test; Fig. 4C; median OS, 35.4 (27.9–42.8) months vs. 60.6 (54.2–67.0) months; p < 0.0001, log-rank test; Fig. 4D), respectively.